Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Micr1on Jul 23, 2010 1:53pm
326 Views
Post# 17292512

RE: RE: TA

RE: RE: TAI read a lot of commeon sense in your post TradingSteve.  I also agree it's a risk investing in SSS at this time but, might be worth the while.  If, (a big IF), phase III goes on, this will mean partnership and thus, money in the project.  I strongly that if Regenesis goes to phase III this will go up to the 30 range and I believe the chances of the placebo working that well on a larger group, it's seem unlikely to me.  I believe in the technology and the company.  Time will tell

What do you see hapening in the mid term, from here to october?

Rgds,

Micr1
Bullboard Posts